101 related articles for article (PubMed ID: 18571149)
21. Improvement of the immune efficacy of carbohydrate vaccines by chemical modification on the GM3 antigen.
Zheng XJ; Yang F; Zheng M; Huo CX; Zhang Y; Ye XS
Org Biomol Chem; 2015 Jun; 13(22):6399-406. PubMed ID: 25982227
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and characterization of ganglioside GM3 derivatives: lyso-GM3, de-N-acetyl-GM3, and other compounds.
Nores GA; Hanai N; Levery SB; Eaton HL; Salyan ME; Hakomori S
Methods Enzymol; 1989; 179():242-53. PubMed ID: 2622350
[No Abstract] [Full Text] [Related]
23. [Ganglioside GM3 from horse erythrocytes: structure and effect on cell proliferation].
Menzeleev RF; Smirnova GP; Chekareva NV; Zvonkova EN; Krasnopol'skiĭ IuM; Shvets VI
Bioorg Khim; 1993 Aug; 19(8):817-24. PubMed ID: 8379955
[TBL] [Abstract][Full Text] [Related]
24. Chemoenzymic synthesis of potentially caged glycosphingolipids [correction of glycoshingolipids] (GSLs): potentially caged lyso-G(M3) and its analogue.
Tuchinsky A; Zehavi U
Chem Phys Lipids; 1998 May; 92(2):91-7. PubMed ID: 9682466
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in the glycosylation of sphingosines and ceramides.
Morales-Serna JA; Boutureira O; Díaz Y; Matheu MI; Castillón S
Carbohydr Res; 2007 Sep; 342(12-13):1595-612. PubMed ID: 17482586
[TBL] [Abstract][Full Text] [Related]
26. Molecular dynamics study of the conformations of glycosidic linkages in sialic acid modified ganglioside GM3 analogues.
Jaishree G; Sharmila DJ
Glycoconj J; 2014 Jul; 31(5):365-86. PubMed ID: 24909815
[TBL] [Abstract][Full Text] [Related]
27. Use of isotopically radiolabelled GM3 ganglioside to study metabolic alterations in Salla disease.
Chigorno V; Valsecchi M; Nicolini M; Sonnino S
Indian J Biochem Biophys; 1997; 34(1-2):150-6. PubMed ID: 9343943
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of ganglioside GM3 and GM4 analogs having mimics of ceramide moieties and their binding activities with influenza virus A.
Nagao Y; Nekado T; Ikeda K; Achiwa K
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1536-42. PubMed ID: 7586078
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of a ganglioside GM3 position isomer, N-acetylneuraminosyl-alpha (2----6)-lactosyl-beta(1----1)-ceramide.
Hasegawa A; Ogawa M; Kiso M
Biosci Biotechnol Biochem; 1992 Mar; 56(3):535-6. PubMed ID: 1368337
[No Abstract] [Full Text] [Related]
30. Synthesis and characterization of lyso-GM3 (II3Neu5Ac Lactosyl sphingosine), de-N-acetyl-GM3 (II3NeuNH2 lactosyl Cer), and related compounds.
Nores GA; Hanai N; Levery SB; Eaton HL; Salyan EK; Hakomori S
Carbohydr Res; 1988 Aug; 179():393-410. PubMed ID: 3208248
[TBL] [Abstract][Full Text] [Related]
31. Chemoenzymatically synthesized GM3 analogues as potential therapeutic agents to recover nervous functionality after injury by inducing neurite outgrowth.
Zheng C; Qu H; Liao W; Bavaro T; Terreni M; Sollogoub M; Ding K; Zhang Y
Eur J Med Chem; 2018 Feb; 146():613-620. PubMed ID: 29407985
[TBL] [Abstract][Full Text] [Related]
32. Fluorous-tagged compound: a viable scaffold to prime oligosaccharide synthesis by cellular enzymes.
Kasuya MC; Cusi R; Ishihara O; Miyagawa A; Hashimoto K; Sato T; Hatanaka K
Biochem Biophys Res Commun; 2004 Apr; 316(3):599-604. PubMed ID: 15033442
[TBL] [Abstract][Full Text] [Related]
33. Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiation.
Go S; Go S; Veillon L; Ciampa MG; Mauri L; Sato C; Kitajima K; Prinetti A; Sonnino S; Inokuchi JI
J Biol Chem; 2017 Apr; 292(17):7040-7051. PubMed ID: 28275055
[TBL] [Abstract][Full Text] [Related]
34. Chemoenzymatically synthesized ganglioside GM3 analogues with inhibitory effects on tumor cell growth and migration.
Zheng C; Guan H; Liu Y; Li Z; Bavaro T; Terreni M; Sollogoub M; Xu J; Zhang Y
Eur J Med Chem; 2019 Mar; 165():107-114. PubMed ID: 30665141
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of a ganglioside GM3 analog containing a hydroxymethyl group in place of the carboxyl group in the N-acetylneuraminic acid unit.
Hasegawa A; Adachi K; Yoshida M; Kiso M
Biosci Biotechnol Biochem; 1992 Mar; 56(3):445-7. PubMed ID: 1368329
[No Abstract] [Full Text] [Related]
36. Chemical and chemoenzymatic synthesis of S-linked ganglioside analogues and their protein conjugates for use as immunogens.
Rich JR; Wakarchuk WW; Bundle DR
Chemistry; 2006 Jan; 12(3):845-58. PubMed ID: 16196067
[TBL] [Abstract][Full Text] [Related]
37. Cell growth arrest by sialic acid clusters in ganglioside GM3 mimetic polymers.
Uemura S; Feng F; Kume M; Yamada K; Kabayama K; Nishimura S; Igarashi Y; Inokuchi J
Glycobiology; 2007 Jun; 17(6):568-77. PubMed ID: 17317719
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological activity of ganglioside GM3 analogues with a (S)-CHF-Sialoside linkage and an alkyne tag.
Ota E; Takeda D; Oonuma K; Kato M; Matoba H; Yoritate M; Sodeoka M; Hirai G
Glycoconj J; 2023 Jun; 40(3):333-341. PubMed ID: 36939991
[TBL] [Abstract][Full Text] [Related]
39. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
40. [Ganglioside GM3 derivatives and their immunomodulating effect].
Diatlovitskaia EV; Koroleva AB; Suskova VS; Emets VI; Sutiusheva LV; Bergel'son LD
Bioorg Khim; 1990 Mar; 16(3):402-6. PubMed ID: 2141471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
